We demonstrated maximum priming of T cells in the tumor tissue with CD8+ T cells (9.5 ± 3.2%) and CD4+ T cells (18.4 ± 7.6%) suggesting local injection of R848 embedded in a smart nanosystem increases cytotoxic activities of T cells. The gene discussed is CD8A; the disease is neoplasm.